MF: C17H17D3N4S MW: 315.45 A radiolabeled Olanzapine, a serotonin (5-HT2) and dopamine (D1/D2) receptor antagonist.
Protein-Interacting Inhibitors, Activators & Substrates
Olanzapine-methyl-d3 (CAS 786686-79-1)
Integrol-d3; LY 170053-d3; Lanzac-d3
Olanzapine-methyl-d3 is a radiolabeled Olanzapine, a serotonin (5-HT2) and dopamine (D1/D2) receptor antagonist
C 17H 17D 3N 4S
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. *
Certificate of Analysis for lot specific data (including water content).
Click on image or enlarge button to enlarge
Olanzapine-methyl-d3 is a deuterated Olanzapine, a serotonin (5-HT2) and dopamine (D1/D2) receptor antagonist with anti-cholinergic activity.
Moore, N.A., et al.: Curr. Opin Invest. Drugs, 2, 281 (1993), Baldwin, D.S. and Montgomery, S.A.: Int. Clin. Psychopharmacol., 10, 239 (1995), Tohen, M., et al.: Am. J. Psychiatry, 156, 702 (1999)
Soluble in Chloroform, Dichloromethane and Ethyl Acetate
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.